MTOR and neoplasm: Moreover, in vivo experiments using animal models demonstrated that interference with PSIP1 expression partially reversed circRNA‐mTOR's promotion of lenvatinib resistance, as evidenced by differences in tumor size, weight, and Ki67 expression (Figure 6H).